Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds

New research shows a marked decline in weight-loss surgeries as GLP-1 meds like Wegovy or Zepbound surge in popularity

Bariatric surgeries fell by more than a quarter between 2022 and 2023, as prescription rates for GLP-1s more than doubled

The medicines' high cost and problems with supply might lead some people to still turn to surgeries, however